除了包容之外:临床试验是否解决了正确的问题?
Ulrik Bak Kirk1,2, Nikoletta Georgiou3, Ron Hillel4
1Department of Public Health, Aarhus University, Aarhus, 8000, Denmark. ubk@ph.au.dk.
Trials
|February 21, 2026
概括
丹麦是欧盟临床试验的领导者,但研究专注于有利可图的领域却忽视了弱势群体. 真正的创新需要为公平的健康研究和知识生成提供包容性的战略.
科学领域:
- 临床研究伦理学
- 卫生公平性健康公平性
- 临床试验的创新 临床试验的创新
背景情况:
- 丹麦在人均临床试验方面领先于欧盟,这表明了创新和行业的吸引力.
- 仅仅临床试验量是研究价值的不足指标,掩盖了差异.
- 研究不成比例地集中在商业上可行的领域,如瘤学和阿尔茨海默病.
研究的目的:
- 批判性地检查专注于临床试验数量的局限性.
- 突出结构和认识不公正导致在研究中忽视某些人群.
- 探索在欧洲临床研究中促进包容性创新的战略.
主要方法:
- 对丹麦临床研究环境的案例研究分析.
- 审查关于包括临床试验的欧洲和国际辩论.
- 评论当前包容性战略对知识生产的影响.
主要成果:
- 临床试验集中在有利可图的地区,忽视了儿童,孕妇,老年人以及患有慢性或不太有利可图的疾病的人.
- 在知识生产中,包容性战略往往优先考虑数字代表性,而不是真正的正义.
- 现有的框架有可能使研究优先级的结构和认识不公正延续.
结论:
- 超越检查清单的包含对于在临床研究中实现正义至关重要.
- 公平的参与和知识生成有利于患者,研究人员和社会.
- 在欧洲临床研究生态系统中,有机会开发更具包容性和以正义为导向的方法.
相关概念视频
Clinical Trials
10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.9K
Clinical Trials: Overview
5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
500
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
500
Preclinical Development: Overview
6.1K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.1K
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
275
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
275
Clinically Relevant Drug Product Specifications: Methods of Establishment
246
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
246


